Status:
COMPLETED
Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine
Lead Sponsor:
Washington University School of Medicine
Conditions:
Oligometastases of the Spine
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In light of the increasing experience with magnetic resonance image-guided radiotherapy (MRgRT) and adaptive planning and advances in magnetic resonance (MR)-only planning, the investigators propose h...
Eligibility Criteria
Inclusion
- At least one disease site deemed to be suitable for treatment with spine SBRT as per radiation oncology evaluation.
- Karnofsky Performance Status (KPS) ≥ 60.
- Deemed medically fit for SBRT by treating physician
- Diagnostic CT with images through the projected treatment area within six months prior to enrollment.
- At least 18 years of age.
- Ability to understand and willingness to sign an IRB approved written informed
Exclusion
- Past history of radiotherapy within the projected treatment field to be treated by MRI-guided SBRT
- Medical contraindication to undergoing MR imaging.
- Spine metastasis resulting in symptomatic spinal cord compression.
- Any other condition that, in the opinion of the treating radiation oncologist, renders the patient unfit for SBRT.
- Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.
Key Trial Info
Start Date :
November 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03878485
Start Date
November 6 2019
End Date
January 9 2024
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110